
FDA Approves Second-Generation Smallpox Vaccine From Acambis
The US Food and Drug Administration (FDA) has approved the ACAM2000 vaccine made by Acambis (Cambridge, UK, www.acambis.com), for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
The US Food and Drug Administration (FDA) has approved the ACAM2000 vaccine made by Acambis (Cambridge, UK,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.